17.3 C
Tuesday, June 25, 2024

Israel. Pharmaceutical company Teva will pay the state of Nevada $193 million to fuel the opioid crisis

Must read

- Advertisement -

Israeli pharmaceutical company Teva has agreed to pay Nevada $193 million to settle claims related to its marketing practices fueling opioid addiction.

Israeli pharmaceutical giant Teva has agreed to pay $193 million to the U.S. state of Nevada as part of a settlement over claims over its marketing practices that fueled opioid addiction.

“The money flowing into Nevada from these settlements will help our state recover and help flow resources to Nevada residents affected by this outbreak,” Nevada Attorney General Aaron Ford said Wednesday.

Pharmaceutical company Teva will pay Nevada $193 millionReuters Archive

- Advertisement -

The state of Nevada, along with other states and thousands of local governments, have accused Teva and other drugmakers of downplaying the risk of addiction to opioid painkillers.

Nevada was one of two states, along with New Mexicowhich last year did not join a nationwide $4.35 billion settlement with an Israeli drugmaker.

Numerous litigation related to opioids

Numerous opioid lawsuits have also targeted drug distributors and pharmacy chains, resulting in settlements worth more than $50 billion.

Teva sells drugs based on fentanyl, which is up to 50 times more potent than heroin and up to 100 times more potent than morphine, and is often prescribed to relieve severe pain associated with, among other things, cancer.

More than half a million people died of drug overdoses in the United States between 1999 and 2020, and opioids played a significant role in this.

Main photo source: Shutterstock

Source link

More articles

- Advertisement -

Latest article